Drug information for METAGLIP

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 2.5MG;250MG Discontinued   GLIPIZIDE; METFORMIN HYDROCHLORIDE metaglip BRISTOL MYERS SQUIBB 21460
2011-02-04 Label

2011-02-03 Letter

2009-11-25 Letter

2009-09-18 Label

2008-08-26 Label

2008-08-20 Letter

2007-07-05 Letter

2007-06-27 Label

2003-04-30 Review

2002-10-21 Letter

2002-10-21 Label
TABLET; ORAL 2.5MG;500MG Discontinued   GLIPIZIDE; METFORMIN HYDROCHLORIDE metaglip BRISTOL MYERS SQUIBB   "
TABLET; ORAL 5MG;500MG Discontinued   GLIPIZIDE; METFORMIN HYDROCHLORIDE metaglip BRISTOL MYERS SQUIBB   "

Drug Adverse Effects information for METAGLIP

Role code Indications Reaction # Reports
C DIABETES MELLITUS FATIGUE 1
C DIABETES MELLITUS HYPERLIPIDAEMIA 1
C DIABETES MELLITUS HYPERTENSION 1
C PRODUCT USED FOR UNKNOWN INDICATION ADVERSE EVENT 1
C PRODUCT USED FOR UNKNOWN INDICATION PRODUCT QUALITY ISSUE 1
Ads by Google